{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T11:41:49Z","timestamp":1768131709539,"version":"3.49.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RRCT"],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.2174\/157488706778250050","type":"journal-article","created":{"date-parts":[[2008,4,18]],"date-time":"2008-04-18T01:24:50Z","timestamp":1208481890000},"page":"217-235","source":"Crossref","is-referenced-by-count":47,"title":["Bcl-2-Targeted Antisense Therapy (Oblimersen Sodium): Towards Clinical Reality"],"prefix":"10.2174","volume":"1","author":[{"given":"Joao","family":"Nuno Moreira","sequence":"first","affiliation":[]},{"given":"Adriana","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Sergio","family":"Simoes","sequence":"additional","affiliation":[]}],"member":"965","container-title":["Reviews on Recent Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/77063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T14:25:54Z","timestamp":1448288754000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1574-8871&volume=1&issue=3&spage=217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/157488706778250050","relation":{},"ISSN":["1574-8871"],"issn-type":[{"value":"1574-8871","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9,1]]}}}